🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Glioblastoma Multiforme of Brain

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells NCT06059690Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: pH Measurement of in vivo tissue A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients NCT06496971Phase 32 sites📍 Taipei📍 Taoyuan NaviFUS Corporation · Tests: Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor NCT05590689Phase 1, Phase 21 site📍 Münster Universität Münster · Tests: Gliolan, Radiodynamic therapy A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma NCT07464925Phase 13 sites📍 Tampa📍 Chicago📍 New York Tetragon Biosciences Ltd · Tests: GLIX1 Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion NCT06333899EARLY Phase 118 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2, Lorlatinib post Radiation Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion NCT05990244NA1 site📍 Shenyang Shengjing Hospital · Tests: Magnetic Resonance Elastography, Assessment and Recording Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188Phase 1, Phase 21 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: LMP744, Conventional Surgery or Biopsy Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors NCT04479696NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Educational Intervention, Questionnaire Administration, Survey Administration, Video The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. NCT03861299NA5 sites📍 Ghent📍 Tilburg📍 Rotterdam Jasper Gerritsen · Tests: Awake craniotomy, Craniotomy under general anesthesia HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) NCT06118723n/a8 sites📍 San Francisco📍 Boston📍 Leuven Jasper Gerritsen · Tests: Supramaximal resection, Maximal safe resection Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age NCT05956821Phase 1, Phase 21 site📍 Miami University of Miami · Tests: SIACI of cetuximab and bevacizumab Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM NCT05902169Phase 356 sites📍 Phoenix📍 Los Angeles📍 Los Angeles CarThera · Tests: SonoCloud-9 (SC9), Carboplatin, Lomustine, Temozolomide Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 NCT07462507Phase 21 site📍 St Louis Washington University School of Medicine · Tests: [C-11]-CS1P1, Brain MRI Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma NCT06090903NA1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Magnetic Resonance Imaging, Medical Chart Review Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions NCT04047264NA1 site📍 Rochester Mayo Clinic · Tests: Microdialysis, Magnetic Resonance Imaging, Computed Tomography Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma NCT07100730Phase 39 sites📍 Gold Coast📍 Melbourne📍 Perth Telix Pharmaceuticals (Innovations) Pty Limited · Tests: TLX-101-Tx + Lomustine, TLX101-Tx Feasibility of FMISO in Brain Tumors NCT03649880Phase 21 site📍 Portland OHSU Knight Cancer Institute · Tests: ¹⁸F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Oxygen Therapy Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care NCT07195591Phase 313 sites📍 Scottsdale📍 Los Angeles📍 Orlando GT Medical Technologies, Inc. · Tests: GammaTile®, External Beam Radiation Therapy, Temozolomide Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant NCT05843253Phase 220 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Ribociclib, Everolimus, Temozolomide (TMZ) A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma NCT07569042Phase 1, Phase 23 sites📍 Kaohsiung City📍 Taichung📍 Taoyuan City Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule, Temozolomide Sitagliptin in Recurrent/Progressive Grade 4 Glioma NCT07541781Phase 11 site📍 Iowa City Kailin Yang, MD, PhD · Tests: Sitagliptin, Bevacizumab The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) NCT06283927n/a8 sites📍 San Francisco📍 Boston📍 Leuven Jasper Gerritsen · Tests: Re-resection, Temozolomide, Lomustine, Re-irradiation, Experimental therapy Implantable Microdevice In Primary Brain Tumors NCT04135807EARLY Phase 11 site📍 Boston Oliver Jonas · Tests: Microdevice Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis NCT06047379Phase 1, Phase 28 sites📍 Beverly Hills📍 Glendale📍 Los Angeles Neonc Technologies, Inc. · Tests: NEO212 Oral Capsule, Ipilimumab, Pembrolizumab, Nivolumab, Regorafenib Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures NCT07413796NA1 site📍 Warsaw Medical University of Warsaw · Tests: Absorbable running intradermal suture, Non-absorbable interrupted transdermal suture Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue NCT05756985n/a1 site📍 Miami Baptist Health South Florida · Tests: Specimen Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy